|
|
||||||||
-opioid receptor antagonists act synergistically to stimulate
colonic propulsion
Departments of Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0551
Opioid neurons
exert a tonic restraint on inhibitory VIP/PACAP/NOS motoneurons of the
enteric nervous system. A decrease in opioid peptide release during the
descending phase of the peristaltic reflex, which underlies propulsive
activity, leads to an increase in vasoactive intestinal peptide (VIP),
pituitary adenylate cyclase-activating polypeptide (PACAP), and nitric
oxide (NO) release and circular muscle relaxation. These effects are
accentuated by opioid receptor antagonists. Endogenous opioid peptides
and selective opioid
-,
- and µ-receptor agonists decreased the
velocity of pellet propulsion in isolated segments of guinea pig colon,
whereas selective antagonists increased velocity in a
concentration-dependent fashion with an order of potency indicating
preferential involvement of
-receptors. 5-HT4 agonists (HTF-919 and
R-093877), which also increase the velocity of propulsion, acted
synergistically with the
-receptor antagonist naltrindole; a
threshold concentration of naltrindole (10 nM) shifted the
concentration-response curve to HTF-919 to the left by 70-fold. A
combination of 10 nM naltrindole with threshold concentrations of the
5-HT4 agonists caused significant
increases in the velocity of propulsion (50 ± 7 to 77 ± 8%).
We conclude that 5-HT4 agonists
and opioid
-receptor antagonists act synergistically to facilitate
propulsive activity in isolated colonic segments.
intestinal smooth muscle; enteric nervous system; gut motility
This article has been cited by other articles:
![]() |
M. Liu, M. S. Geddis, Y. Wen, W. Setlik, and M. D. Gershon Expression and function of 5-HT4 receptors in the mouse enteric nervous system Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1148 - G1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wells, J. L. Bartlett, S. Ananthan, and E. J. Bilsky In Vivo Pharmacological Characterization of SoRI 9409, a Nonpeptidic Opioid {micro}-Agonist/delta -Antagonist That Produces Limited Antinociceptive Tolerance and Attenuates Morphine Physical Dependence J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 597 - 605. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |